Promotions & Moves

Altimmune Appoints M. Scott Harris as CMO

Dr. Harris brings extensive drug development experience having led numerous global clinical studies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Altimmune, Inc. has appointed M. Scott Harris, M.D. as chief medical officer. Dr. Harris succeeds Dr. Sybil Tasker, who resigned June 30, 2019 to continue her professional focus on infectious diseases. Dr. Harris is an accomplished drug development scientist who has led numerous global clinical studies and programs in GI and liver diseases. Previously, he was co-founder and Chief Medical Officer of Lyric Pharmaceuticals, helping raise a $21 million Series A round in 2014. He also served as Ch...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters